p53 and Rbl protein expression: are they prognostically useful in colorectal cancer?
1997

Prognostic Value of p53 and Rbl Protein Expression in Colorectal Cancer

Sample size: 250 publication Evidence: low

Author Information

Author(s): DN Poller, KJ Baxter, NA Shepherd

Primary Institution: Department of Histopathology and Gloucester Gastroenterology Group, Gloucestershire Royal Hospital

Hypothesis

Does the expression of p53 and Rbl proteins have prognostic value in colorectal cancer?

Conclusion

The study suggests that p53 and Rbl protein expression does not appear to be useful in determining the prognosis of operable colorectal cancer.

Supporting Evidence

  • 152 out of 250 cases showed positive p53 staining.
  • 207 out of 250 cases showed positive Rbl staining.
  • There was no relationship between p53 or Rbl expression and overall survival or recurrence-free survival.

Takeaway

This study looked at whether two proteins, p53 and Rbl, can help predict how well patients with colorectal cancer will do. It found that they don't really help with that.

Methodology

The study examined p53 and Rbl protein expression in 250 primary operable colorectal carcinomas using immunohistochemistry and followed patients for a mean of 4.3 years.

Limitations

The study did not find significant associations between protein expression and various clinical factors, and the prognostic significance of aberrant Rbl expression was not independent.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication